Treatment Registry

Company

KERNX Health

KERNX Health publishes compounded semaglutide and compounded tirzepatide, from $209 to $299 a month.

Published by Treatment Registry · Latest research

  • 3 programs
  • 2 identified molecules
  • 3 readings

Read from kernxhealth.com; latest program check November 2026. Individual programs and sources may have earlier verification dates.

Go to KERNX Health

Visit KERNX Health

We earn nothing from this link. It opens KERNX Health's website without a paid referral.

What it costs

Compounded semaglutideInjection · device not recorded$209

first month, including required fees on record · Standard plan: monthly billing, four-week supply

Compounded semaglutideOral tablet$279

first month, including required fees on record · Standard plan: monthly billing, four-week supply

Compounded tirzepatideInjection · device not recorded$299

first month, including required fees on record · Standard plan: monthly billing, four-week supply

At a glance

What to know about KERNX Health

Publisher research · November 2026

KERNX Health offers compounded semaglutide injections at $209 a month, compounded semaglutide tablets at $279 and compounded tirzepatide injections at $299. Its $179 semaglutide and $199 tirzepatide microdosing plans are separate lower-dose options, subject to clinical eligibility. Monthly plans are charged at checkout and renew monthly unless canceled; each supply covers four weeks, which is not a calendar month of medication. The site does not establish a particular injection device or an orally disintegrating tablet.

Optional prepaid plans cover 12, 24 or 52 weeks. Standard semaglutide injections cost $597, $1,074 or $1,807 upfront; tablets cost $777, $1,434 or $2,717; tirzepatide injections cost $717, $1,374 or $2,717. Each microdosing option costs $507, $954 or $1,937 for those terms. The 52-week plan contains thirteen four-week supplies. Prepaid plans renew for the selected term unless canceled. Payment is taken before clinical approval, with a full automatic refund if treatment is not approved. Other refund requests are considered case by case; canceling does not automatically reverse an already processed charge or an order in fulfillment.

KERNX advertises no membership fee or separate consultation fee. Medication, shipping and ongoing support are included. Provider-ordered labs are included in month two when clinically appropriate; later testing can cost extra. The service is cash pay, and insurance reimbursement is not guaranteed. Published all-state availability remains subject to licensure, eligibility, medication availability and law. The individual dispensing pharmacy and clinician are identified during care, rather than assigned by these public pages.

Confirm the prescribed dose, whether the standard or microdosing plan applies, the supply duration, renewal date and dispensing pharmacy before paying. Ask about any testing needed after month two and cancel before the next renewal to prevent future charges. For help with the billing terms, read how to compare a GLP-1 price and how cancellations and refunds differ.

Based on public information, not personal use. Individual eligibility, the assigned pharmacy and a selected patient invoice were not independently verified.

Sources for this overview

Terms

Pharmacy

Individual dispensing pharmacy not disclosed. The terms say the dispensing pharmacy is identified in treatment and fulfillment information.

Across recorded programs · Evidence: November 2026

Membership

None. “No long term commitment · No membership fee · Cancel at any time”

Across recorded programs · Evidence: November 2026

Consultation fee

None. “There is no separate consultation fee.”

Across recorded programs · Evidence: November 2026

States

All 50 states

Across recorded programs · Evidence: November 2026

Programs

More columns to the right? Scroll across the table to see all details.

EntryProgramFormPer month
at its shortest term
Link
EntryTR-1160ProgramCompounded semaglutideFormInjection · device not recordedPer month at shortest term$209Record
Standard plan: monthly billing, four-week supply

Charged at checkout and renews monthly unless canceled. Each supply covers four weeks; this does not establish a calendar month of medication. If treatment is not approved, the full payment is refunded. Billing source: https://kernxhealth.com/pricing.html

EntryTR-1161ProgramCompounded semaglutideFormOral tabletPer month at shortest term$279Record
Standard plan: monthly billing, four-week supply

Charged at checkout and renews monthly unless canceled. Each supply covers four weeks; this does not establish a calendar month of medication. If treatment is not approved, the full payment is refunded. Billing source: https://kernxhealth.com/pricing.html

EntryTR-1162ProgramCompounded tirzepatideFormInjection · device not recordedPer month at shortest term$299Record
Standard plan: monthly billing, four-week supply

Charged at checkout and renews monthly unless canceled. Each supply covers four weeks; this does not establish a calendar month of medication. If treatment is not approved, the full payment is refunded. Billing source: https://kernxhealth.com/pricing.html

Notes

Pricing details, service terms and questions to confirm before enrolling.

November 2026

  1. 1. KERNX describes this as a compounded treatment. The public product page does not establish an injection device. Sources: https://kernxhealth.com/compounded-semaglutide
  2. 2. The monthly headline and four-week supply are separate disclosures. Prepaid options cover 12, 24 or 52 weeks; the 52-week option contains thirteen four-week supplies. These are not calendar-month equivalents. Sources: https://kernxhealth.com/pricing.html https://kernxhealth.com/compounded-semaglutide
Show 14 more notesHide 14 more notes
  1. 3. The assessment is free, with no separate consultation fee. The selected plan is charged at checkout; treatment requires provider approval. If treatment is not approved, the payment is automatically refunded to the original payment method. Sources: https://kernxhealth.com/ https://kernxhealth.com/terms.html
  2. 4. No membership fee is advertised. Plans include medication, shipping and ongoing support. Provider-recommended lab testing is included in month 2; later testing costs are disclosed before proceeding, and patients may use their own provider or lab. Sources: https://kernxhealth.com/ https://kernxhealth.com/faqs.html https://kernxhealth.com/pricing.html
  3. 5. The public telehealth consent allows video, telephone and asynchronous visits and identifies OpenLoop platforms. A particular clinician or visit format is not assigned by the public pages. Sources: https://kernxhealth.com/telehealth
  4. 6. The terms describe service in all 50 states, subject to licensure, clinical eligibility, medication availability and applicable law. This is not a guarantee that any particular prescription can be filled in every state. Sources: https://kernxhealth.com/terms.html
  5. 7. The individual dispensing pharmacy is identified in treatment and fulfillment information rather than named on the public terms. A pharmacy license does not make a compounded medication FDA-approved. Sources: https://kernxhealth.com/terms.html
  6. 8. After approval, estimated pharmacy processing is 1–2 business days and transit another 2–3 business days. Timing may vary with workload, location, holidays and carriers. Sources: https://kernxhealth.com/
  7. 9. KERNX is cash pay and does not bill the insurer. Patients may submit paid invoices themselves, but reimbursement is not guaranteed. Sources: https://kernxhealth.com/ https://kernxhealth.com/terms.html
  8. 10. Cancel before the next renewal to prevent future subscription charges. Cancellation does not automatically reverse a processed charge, completed service or order already in fulfillment. Outside non-approval, refund requests are considered case by case; prescription products generally cannot be returned for reuse or resale. Sources: https://kernxhealth.com/terms.html
  9. 11. The separate lower-dose microdosing offer advertises $179 per month, plus prepaid $507 for 12 weeks, $954 for 24 weeks and $1,937 for 52 weeks. These prices apply to the microdosing program, not the standard-dose offer. The source describes four-week supplies; no calendar-month conversion is made. Sources: https://kernxhealth.com/microdosing-semaglutide https://kernxhealth.com/pricing.html
  10. 12. KERNX describes compounded oral semaglutide tablets taken by mouth; the page does not establish a sublingual or orally disintegrating formulation. Sources: https://kernxhealth.com/compounded-semaglutide-tablets
  11. 13. The monthly headline and four-week supply are separate disclosures. Prepaid options cover 12, 24 or 52 weeks; the 52-week option contains thirteen four-week supplies. These are not calendar-month equivalents. Sources: https://kernxhealth.com/pricing.html https://kernxhealth.com/compounded-semaglutide-tablets
  12. 14. KERNX describes this as a compounded treatment. The public product page does not establish an injection device. Sources: https://kernxhealth.com/compounded-tirzepatide
  13. 15. The monthly headline and four-week supply are separate disclosures. Prepaid options cover 12, 24 or 52 weeks; the 52-week option contains thirteen four-week supplies. These are not calendar-month equivalents. Sources: https://kernxhealth.com/pricing.html https://kernxhealth.com/compounded-tirzepatide
  14. 16. The separate lower-dose microdosing offer advertises $199 per month, plus prepaid $507 for 12 weeks, $954 for 24 weeks and $1,937 for 52 weeks. These prices apply to the microdosing program, not the standard-dose offer. The source describes four-week supplies; no calendar-month conversion is made. Sources: https://kernxhealth.com/microdosing-tirzepatide https://kernxhealth.com/pricing.html

Understand the terms

Before you act

Cite this

Treatment Registry. (2026). KERNX Health: recorded programs and prices. Last verified November 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/kernx-health